Tag: media

New investigative book from Resource Capital Research examines Freeport-McMoRan, West Papua, Indonesia, a vanished US State Department human rights report, FBI interference, and thirty comparative project...

Leading U.S. telecommunications provider leverages Connectbase's Seller Cloud to expand visibility and simplify engagement across the connectivity ecosystemBOSTON, June 17, 2026 /PRNewswire/ -- Connectbase,...

ROCHESTER, N.Y., June 17, 2026 /PRNewswire/ -- Rochester Midland Corporation ("Rochester Midland"), a leading provider of route-based, technical services and specialty chemical products across...

Supporting the growing demand for AI-enabled engineering, cloud modernization and same-time-zone delivery for global enterprisesGUADALAJARA, Mexico and PUNE, India, June 17, 2026 /PRNewswire/ -- News...

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the expiration and final results, as of 5:00 p.m. (New York City time) on June 16, 2026 (the “Expiration Date”), which was also the Extended Early Participation Date (as defined in Verizon’s press release relating to the Exchange Offers and Consent Solicitations dated June 2, 2026 (the “Early Results Press Release”), of its previously announced (i) offers to exchange (the “Exchange Offers”), on behalf of certain of its wholly-owned subsidiaries, any and all of the outstanding series of debt securities listed below (the “Old Notes”) for specified series of newly issued notes of Verizon (collectively, the “New Notes”) and (ii) solicitations of consents (the “Consent Solicitations”), on behalf of such subsidiaries, to the proposed amendments to the indentures governing the Old Notes (with respect to each series of Old Notes, the “Proposed Amendments”) in order to, among other things, eliminate certain of the restrictive covenants and other provisions contained therein, each on the terms and subject to the conditions set forth in the Exchange Offer and Consent Solicitation Statement dated May 11, 2026 (the “Exchange Offer and Consent Solicitation Statement” and, together with the accompanying letter of transmittal (the “Letter of Transmittal”) and eligibility letter, the “Exchange Offer Documents”), as amended by the Early Results Press Release.

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the expiration and final results, as of 5:00 p.m. (New York City time) on June 16, 2026 (the “Expiration Date”), which was also the Any and All Notes Extended Early Participation Date (as defined in Verizon’s press releases relating to the Tender Offers and Consent Solicitations dated June 2, 2026 (collectively, the “June 2026 Press Release”) of its previously announced 11 separate offers, on behalf of certain of its wholly-owned subsidiaries, to purchase for cash any and all of the debt securities listed in Table 1 below (the “Any and All Notes” and such offers, the “Any and All Tender Offers”) as well as solicit consents (the “Consent Solicitations”) to the proposed amendments to the indentures governing the Any and All Notes issued by such subsidiaries (with respect to each series of Any and All Notes, the “Proposed Amendments”) in order to, among other things, eliminate certain of the restrictive covenants and other provisions contained therein on the terms and subject to the conditions set forth in the Offer to Purchase and Consent Solicitation Statement dated May 11, 2026 (the “Offer to Purchase and Consent Solicitation Statement” and, together with the accompanying letter of transmittal, the “Offer Documents”), as amended by the June 2026 Press Release.

New ATM Donation Program Allows Guests to Directly Support Local Shelter ServicesOHKAY OWINGEH, N.M., June 17, 2026 /PRNewswire/ -- Ohkay Casino Hotel has announced...

Customers will enjoy unbeatable savings, exciting giveaways, sweepstakes, samples and moreLAKEWOOD, Colo., June 17, 2026 /PRNewswire/ -- Natural Grocers®, the leading family-operated organic and natural...

Interim phase 1/2 data confirm significant anti-fentanyl antibody production at the lowest dose, with a well-tolerated safety profile across all patients dosed. NEW YORK,...